Snap Shot
- The question: Which common medications add to alcohol’s sedating, impairing, and memory effects, how strong is the evidence, and how do such combinations figure in criminal cases?
- What the research shows: Sleep medications such as zolpidem, benzodiazepines, opioid pain relievers, the muscle relaxant cyclobenzaprine, sedating antihistamines, and some antidepressants add to alcohol’s depressant effects; federal labels and NIAAA guidance warn of increased drowsiness, impaired coordination, slowed breathing, unusual behavior, and, for several classes, memory problems. In a national survey with data from 1999 to 2010, about 42% of U.S. adults who drank also used a prescription medication that can interact with alcohol, and about 78% of drinkers aged 65 or older did, during the same period (the same month and year, not necessarily on the same occasion).
- What it does not show: Most combination evidence concerns sedation, psychomotor impairment, and breathing, not memory for events; memory effects of specific combinations at real-world doses are less studied. The research cannot show how impaired a particular person was, whether a person was in a blackout, or whether a person could consent, without facts about the drug, dose, timing, and the person.
- The law: Incapacity may result from any drug or intoxicant (Art. 120(b)(3)(A), UCMJ; A.R.S. § 13-1401(A)(7)(b)). Voluntary intoxication, including abuse of prescribed medications, is not a defense in Arizona (A.R.S. § 13-503), while intoxication from non-abusive use of a prescribed medication may be treated differently; military law recognizes involuntary intoxication in narrow circumstances (MacDonald; Hensler). Arizona’s DUI statute reaches impairment from any combination of alcohol and drugs (A.R.S. § 28-1381(A)(1)).
- Issues for each side: Either side may need to explain that a medication taken with alcohol can produce more impairment than the alcohol alone; neither side can establish the degree of impairment from the existence of a prescription, and toxicology results require a medication history to interpret.
Many people who drink also take medications that act on the brain. When a complainant, an accused person, or another witness took a sleep aid, an anxiety medication, a pain reliever, a muscle relaxant, or an over-the-counter allergy medicine on the same day as drinking, the question arises whether the combination made the person more impaired, sleepier, or less able to remember than alcohol alone would have. The question appears in sexual assault cases, in impaired-driving cases, and in claims that a medication produced unexpected intoxication.
This paper explains how alcohol-medication interactions work, summarizes the evidence for the classes most often at issue, notes which findings come from controlled human studies, which from labels and postmarketing reports, and which from animal work, and describes how the law treats such combinations. Benzodiazepines, Alcohol, and Memory treats that class in depth, and Alcohol, Cannabis, and Blackouts addresses cannabis.
How Alcohol-Medication Interactions Work
There are two main kinds of interaction (Weathermon & Crabb, 1999). In a pharmacokinetic interaction, alcohol changes how a medication is absorbed or metabolized, or the medication changes how alcohol is handled; because the liver metabolizes both, acute drinking can slow the breakdown of some drugs, while chronic heavy drinking can speed it. In a pharmacodynamic interaction, alcohol and the medication act on the same or related systems in the brain, so their effects add together; sedation is the most familiar example. A forensic toxicology reference describes alcohol as acting additively or synergistically with sedatives, hypnotics, anticonvulsants, antidepressants, tranquilizers, and opioid analgesics, and notes that enhanced depressant effects can occur even at low alcohol levels (Garriott & Manno, 2008).
Such combinations are common. In national survey data from 1999 to 2010, 41.5% of U.S. adults who drank also reported using a prescription medication classed as alcohol-interactive, rising to 77.8% among drinkers aged 65 and older; the most common were cardiovascular, central nervous system, and metabolic agents (Breslow et al., 2015). The study measured use in the same month and year, not simultaneous use on the same occasion.
Federal guidance summarizes the risks by medication class. NIAAA’s patient publication lists, for sleep medications, benzodiazepines, opioid pain relievers, and the muscle relaxant cyclobenzaprine, drowsiness, dizziness, slowed or difficult breathing, impaired motor control, unusual behavior, and memory problems; for sedating antihistamines and many antidepressants it lists drowsiness, dizziness, and increased risk of overdose. It notes that the list is not complete, that older adults are at particularly high risk, and that, on average, women reach higher blood alcohol levels than men from the same amount of alcohol (National Institute on Alcohol Abuse and Alcoholism [NIAAA], 2014). The publication does not give a total count of interacting medications.
Sleep Medications
Zolpidem, the most widely known non-benzodiazepine sleep medication, carries a boxed warning that complex sleep behaviors, including sleepwalking, sleep-driving, and other activities while not fully awake, may occur after use, and that some have resulted in serious injury or death. The label states that patients usually do not remember these events and that they have been reported with zolpidem alone at recommended doses, with or without alcohol or other depressants. It reports that an additive adverse effect on psychomotor performance between alcohol and zolpidem was demonstrated, that the risk of next-day impairment rises with alcohol and other depressants, and that in a controlled study subjects showed anterograde amnesia, impaired next-morning recall of information presented at peak drug effect (Cosette Pharmaceuticals, 2024). Over-the-counter sleep aids containing diphenhydramine or doxylamine are sedating antihistamines, which NIAAA lists among sleep medications that interact with alcohol (NIAAA, 2014).
Sex matters for zolpidem. Women clear zolpidem more slowly than men; at the same dose, peak concentrations and total exposure were about 45% higher in women, and the label therefore recommends a lower starting dose for women (5 mg) than for men (5 or 10 mg) (Cosette Pharmaceuticals, 2024). Because women also reach higher BACs from the same alcohol dose (Mumenthaler et al., 1999), a combination taken at the same dose by a woman and a man would be expected, on average, to produce somewhat higher drug and alcohol exposure in the woman, although body size, food, timing, and tolerance also matter and the two sex differences have not been studied together. These are group findings; they say nothing about any particular person’s levels.
Opioid Pain Relievers
Alcohol increases the depressant effects of opioids such as codeine, morphine, oxycodone, and hydrocodone, raising the risk of respiratory depression and death (Garriott & Manno, 2008). In a controlled crossover study, 12 young and 12 older healthy volunteers took a single 20 mg dose of oxycodone with intravenous alcohol at three levels. Oxycodone alone reduced breathing by 28%; adding alcohol at the highest target level (1 g/L, about 0.1 g/dL) reduced it by a further 19% and increased apneic episodes, and older participants were more affected (van der Schrier et al., 2017). Current benzodiazepine labels carry a boxed warning that combined use with opioids may cause profound sedation, respiratory depression, coma, and death (Viatris Specialty, 2024). This evidence concerns breathing and sedation; it does not measure memory, although NIAAA lists memory problems among the effects of combining opioids and alcohol (NIAAA, 2014).
Muscle Relaxants
Cyclobenzaprine, best known by the brand name Flexeril, is structurally related to the tricyclic antidepressants. Its current label states that it may enhance the effects of alcohol, barbiturates, and other central nervous system depressants, and that, especially with alcohol or other depressants, it may impair the mental or physical abilities needed for hazardous tasks such as driving; it also notes that multiple-drug ingestion, including alcohol, is common in deliberate overdoses (American Health Packaging, 2026). NIAAA lists memory problems among the effects of combining cyclobenzaprine with alcohol (NIAAA, 2014). Controlled human studies of cyclobenzaprine combined with alcohol and measuring memory were not located.
Antihistamines and Antidepressants
First-generation antihistamines such as diphenhydramine and hydroxyzine are sedating, and NIAAA lists drowsiness, dizziness, and overdose risk when they are combined with alcohol; it groups newer, less sedating antihistamines in the same entry (NIAAA, 2014). Antidepressants differ widely. Tricyclic antidepressants add to alcohol’s sedation and central nervous system depression and are a leading cause of overdose deaths, while selective serotonin reuptake inhibitors are much less toxic in combination with alcohol (Garriott & Manno, 2008). NIAAA notes impaired motor control with certain sedating agents such as mirtazapine and quetiapine, and warns that monoamine oxidase inhibitors combined with some alcoholic beverages can cause dangerous rises in blood pressure (NIAAA, 2014).
What Kind of Evidence Supports These Statements
The strength of the evidence varies. The oxycodone study and the zolpidem label’s interaction data come from controlled studies in humans. Many label warnings rest on pharmacology, the known effects of each drug alone, and postmarketing reports, which describe events but cannot establish how often they occur. The NIAAA publication is patient guidance that summarizes risks without citing studies for each entry. Animal research on alcohol and sedatives exists, but it is not the basis for the statements above. Most important for legal questions, the combination studies measured sedation, coordination, driving-related skills, and breathing far more often than memory for events, and they used single, moderate doses in healthy volunteers. The heavier and more varied combinations seen in real cases have rarely been studied directly.
Toxicology adds its own limits. A sedating antihistamine or antidepressant in a toxicology report may reflect a prescription taken as directed, and interpreting such a finding requires a medication history; Drug-Facilitated Sexual Assault: Toxicology, Detection Limits, and What the Results Can Show explains what a positive or negative result can and cannot show.
Limits of the Evidence
Combination studies are few, small, and conducted at moderate doses in healthy adults, often young men or mixed samples whose sex results are not reported separately; the zolpidem pharmacokinetic difference is a notable exception. Older adults are more affected in the studies that included them. Label statements describe risk for patients generally rather than measured effects in people who also drank heavily. Tolerance from regular use of a medication or of alcohol can change how a person responds, and drug levels at the time of an event are seldom known. Above all, group research cannot establish how impaired a particular person was, whether the person formed memories, or whether the person could consent or form intent.
Questions to Ask About This Research
When a label warning is cited to show that a person was severely impaired, counsel can ask what the warning rests on: a controlled interaction study, the drug’s effects alone, or postmarketing reports (American Health Packaging, 2026; Cosette Pharmaceuticals, 2024). When van der Schrier et al. (2017) is cited, counsel can ask what was measured: breathing in 24 volunteers after one oxycodone dose, not memory or behavior. When Breslow et al. (2015) is cited, counsel can ask whether it measured taking a medication on the same occasion as drinking; it did not. When NIAAA’s list of effects is offered, counsel can ask whether memory problems were shown for that combination at the doses taken. When a sex difference is raised, counsel can ask whether the finding concerns the drug at issue, as it does for zolpidem (Cosette Pharmaceuticals, 2024). These questions are explained in “Reading Research Claims: A Guide for Attorneys” on this site.
Medications, Alcohol, and the Law
Federal and Military Standards
Under Article 120(b)(3)(A), UCMJ, sexual assault includes a sexual act on a person incapable of consenting due to impairment by any drug, intoxicant, or other similar substance, when that condition is known or reasonably should be known by the accused; impairment from a medication taken with alcohol falls within that language. Article 120(a)(5) and 18 U.S.C. § 2241(b)(2) address the separate situation in which the accused administers a drug or intoxicant by force or threat, or without the person’s knowledge or consent (permission, in the federal statute), substantially impairing the person’s ability to appraise or control conduct. Expert testimony on drug-alcohol interactions is governed by Federal and Military Rule of Evidence 702 (the federal rule amended December 1, 2023; the amendment took effect in the military rule in 2025, Joint Service Committee on Military Justice, 2025, and practitioners should confirm current text), Daubert v. Merrell Dow Pharmaceuticals, Inc. (1993), Kumho Tire Co. v. Carmichael (1999), and United States v. Houser (1993).
For an accused, voluntary intoxication is not a defense, though it may be considered on actual knowledge, specific intent, willfulness, or premeditation (R.C.M. 916(l)(2)). Military courts recognize involuntary intoxication in narrow circumstances, such as unknowing ingestion or an unexpected reaction to a prescribed medication. In United States v. MacDonald (2014), the Court of Appeals for the Armed Forces described involuntary intoxication as an affirmative defense that the accused must show by clear and convincing evidence and held that the military judge must instruct on it when the evidence reasonably raises it. The Military Judges’ Benchbook (DA Pam 27-9, 2025) has no separate involuntary-intoxication instruction; trial judges have adapted the lack-of-mental-responsibility instructions (Instructions 6-4 and 6-7), under which the members first decide whether the elements are proved beyond a reasonable doubt and only then whether the accused has proved the defense by clear and convincing evidence (see United States v. Rice, 2021, describing that procedure). In United States v. Hensler (1996), which involved alcohol combined with medications, the court held the defense was not raised for later episodes because the accused was on notice that she reacted inappropriately to alcohol (as described in MacDonald).
Case Example. In United States v. MacDonald (2014), a 19-year-old soldier who had been prescribed the smoking-cessation drug varenicline about a month earlier fatally stabbed another soldier; at trial the defense contended that the medication had caused his conduct. The military judge instructed only on lack of mental responsibility. The Court of Appeals for the Armed Forces held that involuntary intoxication from a prescribed medication is distinct from lack of mental responsibility because it does not require a mental disease or defect, that the evidence reasonably raised the defense so the judge had to instruct on it even without a request, and that the error was not harmless; it set aside the findings and sentence and authorized a rehearing. Alcohol was not involved. The case illustrates the framework, not how often such claims succeed: a review of 98 appellate decisions found that courts often treated a prescribed medication taken with alcohol or illicit drugs as voluntary intoxication, particularly when the person had been warned or had prior experience of the effects (Piel, 2015).
Arizona
Arizona provides that temporary intoxication resulting from the voluntary ingestion of alcohol, an illegal substance, or other psychoactive substances, or the abuse of prescribed medications, is not insanity and is not a defense for any criminal act or requisite state of mind (A.R.S. § 13-503). Intoxication from the non-abusive use of a prescribed medication, or from substances administered without the defendant’s knowledge or against the defendant’s will, may be considered on the required mental state (State v. McKeon, 2002; RAJI (Criminal) Standard 39). Whether a medication was taken as prescribed, and whether it was combined with alcohol against label warnings, can therefore matter legally. Sexual assault “without consent” includes a victim incapable of consent by reason of drugs, alcohol, sleep, or similar impairment, where the condition is known or should reasonably have been known to the defendant (A.R.S. § 13-1401(A)(7)(b)). In impaired-driving cases, Arizona prohibits driving while under the influence of intoxicating liquor, any drug, or any combination of them if impaired to the slightest degree (A.R.S. § 28-1381(A)(1)); a separate provision prohibiting any listed drug or its metabolite in the body (A.R.S. § 28-1381(A)(3)) does not apply to a person using a drug as prescribed by a licensed practitioner (A.R.S. § 28-1381(D)). Arizona Rule of Evidence 702, amended effective January 1, 2024 (Ariz. Sup. Ct. Order R-23-0004), governs expert testimony, and experts may not opine on a particular witness’s truthfulness (State v. Lindsey, 1986, 149 Ariz. at 475).
Special Issues in Legal Practice
The principles described above apply with equal force to every party in a legal proceeding. The science operates the same way regardless of who is asking the questions, and the research summarized here does not by itself favor either side. What differs between the parties is not the science but the vantage point — the particular places where these issues tend to surface, and the particular errors each party is best positioned to guard against. The two summaries below identify those recurring issues. They are offered for orientation, not as litigation strategy; in every case the controlling question is what the evidence in that case will, and will not, support, and the expert’s role is to inform the trier of fact rather than to advocate for either side.
Special Issues for Prosecutors
The research supports several propositions prosecutors can legitimately present. Many common medications add to alcohol’s sedating and impairing effects, so a complainant who took a prescribed sleep aid, anxiety medication, pain reliever, or muscle relaxant and then drank may have been more impaired than the number of drinks alone would suggest. Studies of the combination show greater sedation and, in some studies, greater memory impairment than either substance alone at the doses tested; findings differ, and no study has measured blackout risk at the higher BACs common in cases. Memory effects of most such combinations have been studied less than sedation and are not established for a particular person; a gap after a medication taken with alcohol is consistent with the pharmacology for any person, including an accused, and does not by itself show what occurred. Incapacity under military and Arizona law may arise from any drug or intoxicant, including a lawfully prescribed one. Prosecutors are well placed to obtain a complainant’s medication history promptly so that toxicology can be interpreted.
The research also counsels caution. A prescription, or a drug found in a specimen, does not establish the dose taken, its timing, or how impaired the person was, and most combination studies did not measure memory. Testimony that a combination “causes blackouts” goes beyond the evidence for most medications. The same interactions may bear on an accused’s own intoxication and memory.
Special Issues for Defense
The research supports several propositions defense counsel can legitimately present. An accused who took a prescribed medication with alcohol may have experienced more impairment, sleepiness, or memory loss than expected, and in some circumstances intoxication from non-abusive use of a prescribed medication may be considered on mental state in Arizona or raise involuntary intoxication in military practice. It is legitimate to ask what a label warning rests on and whether a study’s doses and measures match the facts.
The research also counsels caution about the limits that apply to the defense. Combining a medication with alcohol despite warnings or prior experience is often treated as voluntary intoxication, and Arizona excludes abuse of prescribed medications from any defense. Memory loss from a combination does not show that conduct was involuntary or that intent was absent. A complainant’s use of a prescribed medication does not by itself show whether an account is accurate or inaccurate, and the same interactions may explain a complainant’s impairment.
This paper is for educational purposes only and is not legal advice. The author is a psychologist, not an attorney; summaries of law are general and must be verified against current authority or with a licensed attorney.
References
American Health Packaging. (2026). Cyclobenzaprine hydrochloride tablets [Package insert]. DailyMed, National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=269bc278-963d-4830-816a-39bb4bf8c936
Breslow, R. A., Dong, C., & White, A. (2015). Prevalence of alcohol-interactive prescription medication use among current drinkers: United States, 1999 to 2010. Alcoholism: Clinical and Experimental Research, 39(2), 371–379. https://doi.org/10.1111/acer.12633
Cosette Pharmaceuticals. (2024). Ambien (zolpidem tartrate) tablets [Package insert]. DailyMed, National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=747949c5-2c91-4909-8a07-71b6826f8e97
Garriott, J. C., & Manno, J. E. (2008). Pharmacology and toxicology of ethyl alcohol. In J. C. Garriott (Ed.), Garriott’s medicolegal aspects of alcohol (5th ed., pp. 25–45). Lawyers & Judges Publishing.
Joint Service Committee on Military Justice. (2025). Amendments to the Military Rules of Evidence since 1984 (G. E. Maggs, Ed.; 2025 ed.). https://jsc.defense.gov/Portals/99/MRE%20Amendments%202025.pdf
Mumenthaler, M. S., Taylor, J. L., O’Hara, R., & Yesavage, J. A. (1999). Gender differences in moderate drinking effects. Alcohol Research & Health, 23(1), 55–64.
National Institute on Alcohol Abuse and Alcoholism. (2014). Harmful interactions: Mixing alcohol with medicines (NIH Publication No. 13-5329). https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/harmful-interactions-mixing-alcohol-with-medicines
Piel, J. (2015). The defense of involuntary intoxication by prescribed medications: An appellate case review. Journal of the American Academy of Psychiatry and the Law, 43(3), 321–328.
van der Schrier, R., Roozekrans, M., Olofsen, E., Aarts, L., van Velzen, M., de Jong, M., Dahan, A., & Niesters, M. (2017). Influence of ethanol on oxycodone-induced respiratory depression: A dose-escalating study in young and elderly individuals. Anesthesiology, 126(3), 534–542. https://doi.org/10.1097/ALN.0000000000001505
Viatris Specialty. (2024). Xanax (alprazolam) tablets [Package insert]. DailyMed, National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb5cf72e-3a41-41a8-9a38-80f974eca33f
Weathermon, R., & Crabb, D. W. (1999). Alcohol and medication interactions. Alcohol Research & Health, 23(1), 40–54.
Legal Authorities
Dep’t of the Army, Pam. 27-9, Military Judges’ Benchbook (July 29, 2025), Instructions 5-21 (voluntary intoxication), 6-4 and 6-7 (lack of mental responsibility).
United States v. Rice, No. ACM 39071 (reh) (A.F. Ct. Crim. App. Jan. 29, 2021) (unpublished).
Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993).
Kumho Tire Co. v. Carmichael, 526 U.S. 137 (1999).
State v. Lindsey, 149 Ariz. 472, 720 P.2d 73 (1986).
State v. McKeon, 201 Ariz. 571 (App. 2002).
United States v. Hensler, 44 M.J. 184 (C.A.A.F. 1996).
United States v. Houser, 36 M.J. 392 (C.M.A. 1993).
United States v. MacDonald, 73 M.J. 426 (C.A.A.F. 2014).
10 U.S.C. § 920 (Article 120, Uniform Code of Military Justice).
18 U.S.C. § 2241(b)(2).
Ariz. Rev. Stat. Ann. § 13-503.
Ariz. Rev. Stat. Ann. § 13-1401.
Ariz. Rev. Stat. Ann. § 28-1381.
Fed. R. Evid. 702.
Mil. R. Evid. 702.
Ariz. R. Evid. 702.
Ariz. Sup. Ct. Order R-23-0004 (amending Ariz. R. Evid. 702, effective Jan. 1, 2024).
Rule for Courts-Martial 916(l)(2).
Revised Arizona Jury Instructions (Criminal), Standard Criminal 39.
Related topic papers: Benzodiazepines, Alcohol, and Memory · Alcohol, Cannabis, and Blackouts · Causes of Blackouts: Drinking Pattern and Individual Risk Factors · Alcohol, Sleep, and Memory · Voluntary Intoxication, Blackout, and Criminal Responsibility
Related topics from Arizona Forensic Services: Counterintuitive Testimony: Drug-Facilitated Sexual Assault: Toxicology, Detection Limits, and What the Results Can Show · Courts-Martial